Literature DB >> 16378781

Variability in the use of thromboprophylaxis and outcomes in critically ill medical patients.

Krista L Lentine1, Kara E Flavin, Michael K Gould.   

Abstract

PURPOSE: To describe practices for preventing venous thromboembolism in critically ill medical patients and to identify associations between prophylactic measures and survival.
METHODS: We reviewed the records of all medical admissions to the intensive care units of a university hospital and an affiliated Veterans Affairs hospital over a 1-year period. We recorded patients' demographic characteristics, risk factors for venous thromboembolism, methods of prophylaxis, and in-hospital deaths.
RESULTS: We identified 272 critically ill medical patients who received intensive care for at least 24 hours. Some form of prophylaxis was used in 205 patients (75%), including pharmacologic prophylaxis alone in 55 (20%), mechanical prophylaxis alone in 102 (38%), and both methods in 48 (18%). In-hospital mortality rates were 23% (24/103) for patients who received pharmacologic prophylaxis, and 36% (61/169) for those who received mechanical prophylaxis alone or no prophylaxis (P=.03). After adjusting for demographic characteristics, risk factors for thrombosis and severity of illness, the odds of death were 55% lower in patients who received pharmacologic prophylaxis (odds ratio [OR]=0.45; 95% confidence interval (CI): 0.22 to 0.93; P=.03). Similar results were obtained in propensity-adjusted and propensity-stratified analyses. Use of mechanical prophylaxis was not associated with survival (OR=0.88; 95% CI 0.44 to 1.77; P=.73).
CONCLUSION: In this cohort of critically ill medical patients, pharmacologic but not mechanical thromboprophylaxis was associated with reduced risk of in-hospital death. This hypothesis must be tested in randomized trials.

Entities:  

Mesh:

Year:  2005        PMID: 16378781     DOI: 10.1016/j.amjmed.2004.12.025

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  4 in total

1.  Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Susan R Kahn; Wendy Lim; Andrew S Dunn; Mary Cushman; Francesco Dentali; Elie A Akl; Deborah J Cook; Alex A Balekian; Russell C Klein; Hoang Le; Sam Schulman; M Hassan Murad
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit.

Authors:  François Lauzier; John Muscedere; Eric Deland; Demetrios Jim Kutsogiannis; Michael Jacka; Diane Heels-Ansdell; Mark Crowther; Rodrigo Cartin-Ceba; Michael J Cox; Nicole Zytaruk; Denise Foster; Tasnim Sinuff; France Clarke; Patrica Thompson; Steven Hanna; Deborah Cook
Journal:  Crit Care       Date:  2014-04-25       Impact factor: 9.097

3.  [Prevention of thromboembolism in German intensive care units : Results of a nationwide survey].

Authors:  P Hilbert; P Teumer; R Stuttmann
Journal:  Anaesthesist       Date:  2008-03       Impact factor: 1.041

4.  Prophylaxis and Incidence of Symptomatic Deep Vein Thrombosis in Indian Patients with Sepsis: DETECT-Deep Vein Thrombosis Registry.

Authors:  Nagarajan Ramakrishnan
Journal:  Indian J Crit Care Med       Date:  2017-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.